Big drug makers keeping a close eye on Neurontin lawsuit

04/19/2004 | U.S. News & World Report

The legal battle over the marketing practices surrounding the epilepsy drug Neurontin and its off-label uses has major pharmaceutical companies waiting anxiously for a decision. The suit claims Parke-Davis, now part of Pfizer, engaged in illegal off-label promotion, and a victory for the plaintiff could lead to investigations of other drug companies' practices in the off-label area and force companies to look closely at their compliance and training practices. Some say the federal government is interested in a crackdown on off-label uses to cut its costs under the new Medicare prescription drug law.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA